Politics

Politics

Biotech venture capitalists form a lobbying coalition to join the drug pricing debate

By Nicholas Florko

Politics

Elizabeth Warren’s health care evolution has earned her friends on the left, but foes in her home state

By Lev Facher — STAT and Liz Goodwin — Boston Globe

Politics

A new bill would let more doctors prescribe addiction treatments without waiting for insurers’ permission

By Lev Facher

Politics

In a rare political move, prominent biotech venture capitalists speak out against Pelosi’s drug pricing bill

By Nicholas Florko

Politics

Mass. governor — and one-time insurance executive — eyes a legacy-defining revamp of state’s health care

By Priyanka Dayal McCluskey — Boston Globe and Matt Stout — Boston Globe

Biotech

It’s tiny biotechs — not big drug makers — that fear ‘nuclear winter’ from Pelosi’s drug pricing bill

By Nicholas Florko

Democratic Presidential Candidates Participate In First Debate Of 2020

Politics

More than ever, Democratic presidential hopefuls want to take on pharma. Here’s how they’d do it

By Lev Facher

Politics

Top Trump official suggests tobacco regulation distracts from FDA mission

By Lev Facher

Pharmalot

If Trump were to place tariffs on Swiss drugs, U.S. patients are most likely to get hurt

By Ed Silverman

Pharmalot

What money? The CDC is urged to acknowledge industry funding

By Ed Silverman

Politics

Sen. Cassidy on Trump drug plan: Price index still preferable to imports

By Lev Facher

Politics

Trump nominates MD Anderson’s Stephen Hahn to lead FDA

By Lev Facher

Politics

Insurance, pharma figures spar over drug price legislation’s innovation impact

By Lev Facher

Health Tech

Democrats ‘continue to have concerns’ about FDA program to streamline regulation of medical software

By Rebecca Robbins

Politics

Democrats’ new logic on drug pricing: Developing slightly fewer medicines is OK if it means lower prices

By Lev Facher

Politics

Nonpartisan congressional report suggests Pelosi’s drug pricing bill could be found unconstitutional

By Nicholas Florko

Politics

How Joe Grogan shaped 5 key drug pricing policy proposals

By Lev Facher

Biotech

This small biotech is suing the Trump administration to get its drug covered

By Nicholas Florko

Politics

After 10 hours and a pile of rejected amendments, Democrats advance their drug pricing bill out of two key committees

By Nicholas Florko

Politics

Pelosi: Democrats will name marquee drug pricing bill for late Rep. Cummings

By Lev Facher

Politics

House progressives plot overhaul of Pelosi drug pricing bill

By Lev Facher and Nicholas Florko

Pharmalot

A small biotech raises the price on its cancer drug by 20% this year, but will anyone notice?

By Ed Silverman

Politics

With a new lobbying group and a day at the White House, synthetic biology looks for footing in Washington

By Nicholas Florko and Rebecca Robbins

Politics

Buttigieg’s balancing act: He wants far lower drug prices even as he hopes the drug industry will ‘thrive’

By Nicholas Florko

Politics

Buttigieg unveils an aggressive plan for lowering drug prices

By Nicholas Florko and Lev Facher

Stephen Hahn, Trump’s FDA nominee, pledges ‘bold action’ on vaping but sidesteps questions on flavor ban

12 burning questions for Stephen Hahn, Trump’s pick to lead FDA

Mystery solved: The American Hospital Association and CVS Health formed a shadowy, anti-pharma group with deep GOP ties

Warren and Sanders: More scrutiny needed of commercial boards that decide whether to green-light clinical trials

Biotech venture capitalists form a lobbying coalition to join the drug pricing debate

Elizabeth Warren’s health care evolution has earned her friends on the left, but foes in her home state

A new bill would let more doctors prescribe addiction treatments without waiting for insurers’ permission

In a rare political move, prominent biotech venture capitalists speak out against Pelosi’s drug pricing bill

Mass. governor — and one-time insurance executive — eyes a legacy-defining revamp of state’s health care

It’s tiny biotechs — not big drug makers — that fear ‘nuclear winter’ from Pelosi’s drug pricing bill

More than ever, Democratic presidential hopefuls want to take on pharma. Here’s how they’d do it

Top Trump official suggests tobacco regulation distracts from FDA mission

If Trump were to place tariffs on Swiss drugs, U.S. patients are most likely to get hurt

What money? The CDC is urged to acknowledge industry funding

Sen. Cassidy on Trump drug plan: Price index still preferable to imports

Trump nominates MD Anderson’s Stephen Hahn to lead FDA

Insurance, pharma figures spar over drug price legislation’s innovation impact

Democrats ‘continue to have concerns’ about FDA program to streamline regulation of medical software

Democrats’ new logic on drug pricing: Developing slightly fewer medicines is OK if it means lower prices

Nonpartisan congressional report suggests Pelosi’s drug pricing bill could be found unconstitutional

How Joe Grogan shaped 5 key drug pricing policy proposals

This small biotech is suing the Trump administration to get its drug covered

After 10 hours and a pile of rejected amendments, Democrats advance their drug pricing bill out of two key committees

Pelosi: Democrats will name marquee drug pricing bill for late Rep. Cummings

House progressives plot overhaul of Pelosi drug pricing bill

A small biotech raises the price on its cancer drug by 20% this year, but will anyone notice?

With a new lobbying group and a day at the White House, synthetic biology looks for footing in Washington

Buttigieg’s balancing act: He wants far lower drug prices even as he hopes the drug industry will ‘thrive’

Buttigieg unveils an aggressive plan for lowering drug prices